Skip to content
Primary Menu
Clinical
Medications for Opioid Use Disorder (MOUD)
Pain or Opioid Withdrawal in Hospitalized Patients
Low dose/Microdose Buprenorphine Instructions
Buprenorphine Induction Pathway
All About Xylazine
Substance Use Navigator Team
Success Stories
Education
Working as a Peer in Recovery
How to Mitigate Stigma
All About the X Waiver
Addiction Medicine Interest Group
Research
Clinical Trials
Research in the News
Publications
Harm Reduction
All About Fentanyl
All About Xylazine
How to Use Narcan
Harm Reduction Interest Group
Trainings & Events
Trainings
Upcoming Events
Events Archive
News & Policy
Policy
About Us
Donate
Leadership
CAMP Team
Advisory Board
Newsletters
Get Help
Advisory Board
Michael A. Ashburn, MD, MPH, MBA
Read More
Sara S. Bachman, PhD
Read More
Peggy Compton, PhD, RN, FAAN
Read More
Deborah A. Driscoll, MD
Read More
Lee A. Fleisher, MD
Read More
Heather Klusaritz, PhD, MSW
Read More
Maria Oquendo, MD, PhD
Read More
Karen M. Puopolo, MD, PhD
Read More
Roy Rosin, MBA
Read More
Theodore W. Ruger, JD
Read More
Benjamin Sun, MD, MPP
Read More
Clinical
Medications for Opioid Use Disorder (MOUD)
Pain or Opioid Withdrawal in Hospitalized Patients
Low dose/Microdose Buprenorphine Instructions
Buprenorphine Induction Pathway
All About Xylazine
Substance Use Navigator Team
Success Stories
Education
Working as a Peer in Recovery
How to Mitigate Stigma
All About the X Waiver
Addiction Medicine Interest Group
Research
Clinical Trials
Research in the News
Publications
Harm Reduction
All About Fentanyl
All About Xylazine
How to Use Narcan
Harm Reduction Interest Group
Trainings & Events
Trainings
Upcoming Events
Events Archive
News & Policy
Policy
About Us
Donate
Leadership
CAMP Team
Advisory Board
Newsletters
Get Help